Abstract
Adhesion formation may be the result of prolonged deposition of excess fibrin, which is produced during coagulation and restoration of vascular hemostasis.1 The ability to remove deposited fibrin is dependent on the postsurgical environment and the cellular milieu. At surgery, multifaceted insults may be delivered to the tissue that will modulate the process of postsurgical fibrinolysis and repair. These may include (1) the disruption of the tissue architecture; (2) removal of cells from the surface of tissues by abrasion or drying; (3) disruption of vascular integrity; and (4) the introduction of foreign bodies. However, as a result of any surgical injury, an inflammatory response is initiated that allows the deposition of fibrin and may modulate the removal of the deposited fibrin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
diZerega GS, Rodgers KE. Intraperitoneal adhesions. In: The Peritoneum. New York: Springer-Verlag; 1992; 274–307.
Simpson DM, Ross R. The neutrophilic leukocyte in wound repair. A study with antineutrophil serum. J Clin Invest. 1972; 51: 2009–2011.
Orita H, Nakamura RM, DiZerega GS. Kinetic analysis of postoperative peritoneal healing: incorporation of proline and glucosamine by exudative and tissue repair cells. Surg Forum. 1985; 36: 467–468.
Shimanuki T, Nakamura RM, diZerega GS. A kinetic analysis of peritoneal fluid cytology and arachidonic acid metabolism after abrasion and reabrasion of rabbit peritoneum. J Surg Res. 1986; 41: 245–251.
Leibovich SJ, Ross R. The role of macrophages in wound repair. A study with hydrocortisone and anti-macrophage serum. Am J Pathol. 1975; 78: 71–76.
diZerega GS, Rodgers KE. Growth factors. In: The Peritoneum. New York: Springer-Verlag; 1992; 57–122.
Rodgers KE, DiZerega GS. Modulation of peritoneal re-epithelialization by postsurgical macrophages. J Surg Res. 1991; 53: 542–548.
Rodgers KE, DiZerega GS. Function of peritoneal exudate cells after abdominal surgery. J Invest Surg. 1993; 6: 9–23.
Golan A, Stolik O, Wexler S, Langer R, Ber A, David MR. Prostaglandins—a role in adhesion formation. An experimental study. Acta Obstet Gynecol Scand. 1990; 69: 339–341.
Golan A, Bernstein T, Wexler S, Neuman M, Bukovsky I, David MP. The effect of prostaglandins and aspirin: an inhibitor of prostaglandin synthesis on adhesion formation in rats. Hum Reprod (Eynsham). 1991; 6: 251–254.
Raferty AT. Regeneration of parietal and visceral peritoneum. Brit JSurg. 1973; 60: 293.
diZerega GS, Rodgers KE. Fibroblasts and tisssue repair cells. In: The Peritoneum. New York: Springer-Verlag. 1992; 22–36.
Martin BM, Gimbrone MA Jr, Unanue ER, Cotran RS. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol. 1981; 126: 1510.
Takemura R, Zena W. Secretory products of macrophages and their physiological function. Am J Physiol. 1984; 246: C8.
Leibovich SJ. Production of macrophage-dependent fibroblast-stimulating activity (M-FSA) by murine macrophages. Exp Cell Res. 1978; 113: 47.
Lemke H, Huget R, Flad HD. Biochemical characterization of a factor released by macrophages. Cell Immunol. 1975; 18: 70.
Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982; 128: 2177.
Fukasawa M, Yanagihara DL, Rodgers KE, diZerega GS. The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J Surg Res. 1989; 47: 45.
Leibovich SJ, Wiseman DM, Nuseir N. Functionally heterogeneous macrophage sub-populations. In: Rovee D, Pines E, eds. Proceedings of the 2nd International Symposium on Tissue Repair. New York: A. R. Liss, 1987: 159–167.
Pledger WJ, Stiles CD, Antoniades HN, Scher CD. An ordered sequence of events is required before BALB/c-3Y3 cells become committed to DNA synthesis. Proc Natl Acad Sci USA. 1978; 74: 2839.
Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type B transforming growth factor: a bifunctional regulatory of cellular growth. Proc Natl Acad Sci USA. 1985; 82: 199.
diZerega GS, Rodgers KE. Peritoneal macrophages. In: The Peritoneum. New York: Springer-Verlag; 1992: 171–209.
Curnette JT, Babior BM. Biological defense mechanisms: the effects of bacteria and serum on superoxide production by the granulocyte. J Clin Invest. 1974; 53: 1662–1666.
Fukasawa M, Bryant SM, diZerega GS. Superoxide anion production by postsurgical macrophages. J Surg Res. 1988; 45: 382–388.
Kuraoka S, Campeau JD, Nakamura RM, diZerega GS. Modulation of postsurgical macrophage function by early postsurgical polymorphonuclear leukocytes. J Surg Res. 1992; 53: 245–250.
Randall RW, Eakins KE, Higgs GA. Inhibition of arachidonic acid cyclooxygenase and lipo-oxygenase activities by indomethacin and compound BW755. Agents Actions. 1980; 10: 553–555.
Schnyder J, Dewald B, Baggiolini M. Effects of cyclooxygenase inhibtors and prostaglandin E2 on macrophage activation in vitro. Prostaglandins. 1981; 22: 411–419.
Vanderhock JY, Bailey JM. Activation of a 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen. JBiol Chem. 1984; 259: 6752–6755.
Rodgers KE, Ellefson D, Girgis W, Scott L, diZerega GS. Effects of tolmetin sodium dihydrate on normal and postsurgical peritoneal cell function. Int J lmmunopharmacol. 1988; 10: 111–120.
Postlethwaite AE, Lachman LB, Mainadri CL, Kang AH. Interleukin-1 stimulation of collagenase production by cultured fibroblasts. J Exp Med. 1983; 157: 801–806.
Bronson RE, Bertiolami CN, Siebert EP. Modulation of fibroblast growth and glycosaminoglycan synthesis by interleukin-1. Collagen Relat Res. 1987; 7: 323–332.
Matsushima K, Bano M, Kidwell WR, Oppenheim JJ. Interleukin-1 increases collagen type IV production by murine mammary epithelial cells. J Immunol. 1985; 134: 904–909.
Bevilacqua MP, Pober JS, Majeau GR, Contran RA, Gimbrone MA. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160: 618–623.
Bevilacqua MP, Schleef RR, Gimbrone MA, Loskutoff DJ. Regulation of the fibribolytic system of cultures of human endothelium by interleukin-1. J Clin Invest. 1986; 78: 587–591.
Emeis JJ, Kooestra J. Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultures endothelial cells. J Exp Med. 1986; 163: 1260–1266.
Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin-1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med. 1986; 163: 1545–1547.
Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986; 163: 740–745.
McBride WH, Mason K, Withers HR, Davis C. Effect of interleukin-1, inflammation, and surgery on the incidence of adhesion formation after abdominal irradiation in mice. Cancer Res. 1898; 49: 169–173.
Herschlag A, Hemess IGO, Wimberly HC, Bleven ML, Diamond MP, Polan ML. The effect of interleukin-1 on adhesion formation in the rat. Am J Obstet Gynecol. 1991; 165: 771–774.
Abe H, Rodgers KE, Ellefson D, diZerega GS. Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery. JInvest Surg. 1991; 4: 141–151.
Ko SD, Page RC, Narayanan AS. Fibroblast heterogeneity and prostaglandin regulation of subpopulation. Proc Natl Acad Sci USA. 1977; 74: 3429–3440.
Phan SH, McGarry BM, Loeffler KM, Kunkel SL. Regulation of macrophage derived fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biol. 1987; 42: 106–113.
Korn JH, Halushka PV, LeRoy EC. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest. 1980; 65: 542–554.
Unkeless J, Gordon S, Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974; 139: 834–850.
Drapler JC, Pen JF. Involvement of prostaglandins in lipoplysaccharide-mediated regulation of plasminogen activator synthesis by inflammatory macrophages. Int J Immunopharmacol. 1984; 6: 345–352.
Orita H, Campeau JD, Gale JA, Nakamura RM, diZerega GS. Differential secretion of plasminogen activator by postsurgical activated macrophages. J Surg Res. 1986; 41: 569–573.
Fukasawa M, Campeau JD, Girgis W, Bryant SM, Rodgers KE, diZerega GS. Production of protease inhibitors by postsurgical macrophages. J Surg Res. 1989; 46: 256–261
Kuroaka S, Campeau JD, Rodgers KE, Nakamura RM, diZerega GS. Effects of interleukin 1 on postsurgical macrophage secretion of protease and inhibitor activites. J Surg Res. 1992; 52: 71–78.
Albrechtsen OK. The fibrinolytic activity of human tissues. Br J Haematol. 1957; 3: 284–291.
Albrechtsen OK. The fibrinolytic activity of animal tissues. Acta Physiol Scand. 1957; 39: 284–290.
Porter JM, McGregor FH, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum. 1969; 20: 80–82.
Merlo G, Fausome G, Barbero C, Castagna B. Fibrinolytic activity of the human peritoneum. Eur Surg Res. 1980; 12: 433–438.
Vipond MN, Whawell SA, Thompson JN, Dudley JAF. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet. 1990; 335: 1120–1122.
van der Poll T, Levi M, Buller HR, van Deventer SJA, de Boer JP, Hack CE, ten Cate JW. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med. 1991; 175: 729–732.
Gervin AS, Puckett CL, Silver D. Serosal hypofibrinolysis. A cause of postoperative adhesions. Am J Surg. 1973; 125: 80–88.
Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. Eur Surg Res. 1981; 13: 397–401.
Buckman RF Jr, Maij MC, Buckman PD, Hufnagel HV, Gervin AS. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res. 1976; 21: 67–76.
van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 1990; 75: 1490–1497.
Hau T, Payne D, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet. 1979; 148: 415–418.
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971; 231: 232–35.
Flower R, Gryglewski R, Herbaczynska-Cedro K, Vane JR. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature New Biol. 1972; 238: 104–106.
Larsson B, Svanberg SG, Swolin K. Oxyphenbutazone-an adjuvant to be used in prevention of adhesions in operations for fertility. Fertil Steril. 1977; 28: 807–808.
Kapur BML, Talwar JR, Gulati SM. Oxyphenbutazone: anti-inflammatory agent in prevention of peritoneal adhesions. Arch Surg. 1969; 98: 301–302.
Siegler AM, Kontopoulos V, Wang CF. Prevention of postoperative adhesions in rabbits with ibuprofen, a nonsteroidal anti-inflammatory agent. Fertil Steril. 1980; 34: 46–49.
Nishimura K, Nakamura RM, diZerega GS. Biochemical evaluation of postsurgical wound repair: prevention of intraperitoneal adhesion formation with ibuprofen. J Surg Res. 1983; 34: 219–226.
Nishimura K, Shimanuki T, diZerega GS. Ibuprofen in the prevention of experimentally induced postoperative adhesions. Am J Med. 1984; 77: 102–106.
Nishimura K, Nakamura RM, diZerega GS. Ibuprofen inhibition of postsurgical adhesion formation: a time and dose response biochemical evaluation of rabbits. JSurg Res. 1984; 36: 115–124.
Rodgers KE, Bracken K, Richer L, Girgis W, diZerega GS. Inhibition of postsurgical adhesions by loposomes containing nonsteroidal anti-inflammatory drugs. Int Jlnfertil. 1990; 35: 315–320.
Rodgers KE, Girgis W, Johns D, diZerega GS. Intraperitoneal tolmetin prevents postsurgical adhesion formation in rabbits. Int Jlnfertil. 1990; 35: 40–45.
Rodgers KE. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of postsurgical adhesion. In: diZerega GS, Malinak LR, Diamond MD, Linsky CP, eds. Treatment of Adhesions. New York: Wiley-Liss; 1990: 119–130.
Shimanuki T, Nishimura K, diZerega GS. Prevention of postoperative peritoneal adhesions in rabbits with ibuprofen. Semin Reprod Endocrinol. 1985; 3: 295–300.
Plescia OJ, Smith AH, Greenwich K. Subversion of immune system by tumor cells and the role of prostaglandins. Proc Natl Acad Sci USA. 1975; 72: 1848–1853.
Bonney RJ, Davies P. Possible autoregulatory functions of the secretory products of mononuclear phagocytes. Contemp Top Immunol. 1984; 10: 199–223.
Ratzan KR, Musher DM, Keusch GT, Weinstein L. Correlation of increased metabolic activities resistance to infection, enhanced phagocytosis and inhibition of bacterial growth by macrophages from listeria and BCG-infected mice. Infect Immunol. 1972; 5: 499–503.
Johnston RB, Godzik CA, Cohn ZA. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978; 142: 115–122.
Hibbs JB, Chapman HA, Weinberg JB. The macrophage as an antineoplastic surveilliance cell: biological perspective. J Reticuloendothel Soc. 1978; 24: 549–556.
Rodgers KE, Ellefson D, Girgis W, diZerega GS. Protease and protease inhibitor secretion by post-surgical macrophages following in vitro exposure to tolmetin. Agents Actions. 1992; 36: 248–257.
Rodgers KE, Ellefson DD, Girgis W, diZerega GS. Modulation of postsurgical cell infiltration and fibrinolytic activity by tolmetin in two species. J Surg Res. 1994; 56: 314–325.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rodgers, K.E. (1997). Biochemical Messengers in Postsurgical Repair and Adhesion Formation. In: diZerega, G.S., et al. Pelvic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1864-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1864-7_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7316-5
Online ISBN: 978-1-4612-1864-7
eBook Packages: Springer Book Archive